Comparison of four different cardiac troponin assays in patients with end-stage renal disease on chronic haemodialysis

References

• Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36: 959–69
   PubMed Web of Science ®Google Scholar
• Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991; 67: 1360–7
   PubMed Web of Science ®Google Scholar
• Dean KJ, Wu AH. Biochemistry and molecular biology of troponin I and T. Cardiac Markers. 2nd ed. Humana Press, TotowaNJ, USA. 2003. pp. 193–204.
   Google Scholar
• Fleming SM, Daly KM. Cardiac troponins in suspected acute coronary syndrome: a meta-analysis of published trials. Cardiology 2001; 95: 66–73
   PubMed Web of Science ®Google Scholar
• Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation 1997; 96: 2578–85
   PubMed Web of Science ®Google Scholar
• Christenson RH, Duh SH, Newby LK, Ohman EM, Califf RM, Granger CB, et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem. 1998; 44: 494–501
   PubMedGoogle Scholar
• Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108: 833–8
   PubMed Web of Science ®Google Scholar
• Christensen H, Johannesen HH, Christensen AF, Bendtzen K, Boysen G. Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha. Cerebrovasc Dis. 2004; 18: 194–9
   PubMed Web of Science ®Google Scholar
• Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H, et al. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem. 2003; 49: 2020–6
   PubMed Web of Science ®Google Scholar
• Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211–7
   PubMed Web of Science ®Google Scholar
• US Renal Data System . 1999. Annual Data Report 1999. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease.
   Google Scholar
• Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941–5
   PubMed Web of Science ®Google Scholar
• Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem. 2004; 50: 2279–85
   PubMed Web of Science ®Google Scholar
• Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000; 46: 1345–50
   PubMed Web of Science ®Google Scholar
• Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102: 1964–9
   PubMed Web of Science ®Google Scholar
• Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, et al. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta. 2001; 312: 69–79
   PubMedGoogle Scholar
• Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088–96
   PubMed Web of Science ®Google Scholar
• deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290: 353–9
   PubMed Web of Science ®Google Scholar
• Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006; 92: 804–9
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney Int. 2002; 62: 1884–90
   PubMed Web of Science ®Google Scholar
• Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic haemodialysis and new cardiac markers evaluation (CHANCE) study. Nephrol Dial Transplant 2001; 16: 1452–8
   PubMed Web of Science ®Google Scholar
• Ooi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem. 2000; 46: 338–44
   PubMed Web of Science ®Google Scholar
• Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, Van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004; 109: 23–5
   PubMed Web of Science ®Google Scholar
• Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J. 26; 2005: 1115–40
   Google Scholar
• Kober L, Torp-Pedersen C, Carlsen J, Videbaek R, Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). Trandolapril cardiac evaluation. Eur Heart J. 1994; 15: 1616–20
   PubMed Web of Science ®Google Scholar
• O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005; 23: 697–701
   PubMed Web of Science ®Google Scholar
• Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem. 2004; 50: 327–32
   PubMed Web of Science ®Google Scholar
• Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000; 102: 1221–6
   PubMed Web of Science ®Google Scholar
• Ooi DS, Veinot JP. Cardiac troponin in dialysis patients. Can J Cardiol. 2003; 19: 1545–6
   PubMedGoogle Scholar
• Sommerer C, Heckele S, Schwenger V, Katus HA, Giannitsis E, Zeier M. Cardiac biomarkers are influenced by dialysis characteristics. Clinical Nephrology 2007; 68: 392–9
   PubMed Web of Science ®Google Scholar
• Ooi DS, Zimmerman D, Graham J, Wells GA. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem. 2001; 47: 412–7
   PubMedGoogle Scholar